# Gabapral in Pediatric IBS

> **NCT05737277** · NA · UNKNOWN · sponsor: **Azienda Ospedaliera "Sant'Andrea"** · enrollment: 20 (estimated)

## Conditions studied

- Bifidobacterium Adolescentis PRL2019
- IBS
- Pediatric

## Interventions

- **DRUG:** Gabapral
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05737277
- **Lead sponsor:** Azienda Ospedaliera "Sant'Andrea"
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-01
- **Primary completion:** 2023-05-01
- **Final completion:** 2023-07-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05737277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05737277, "Gabapral in Pediatric IBS". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT05737277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*